Global Pharmaceuticals & Biotech Most Popular Stocks

Cleo Diagnostics

Market Cap: AU$48.8m

A biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.

Shenzhen Neptunus Interlong Bio-technique

Market Cap: HK$248.3m

Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.

Natural Capsules

Market Cap: ₹2.8b

Engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally.

SCM Lifescience

Market Cap: ₩44.6b

Operates in the stem cell therapy, CMO, contract research and consulting, and cosmetic businesses.

Akari Therapeutics

Market Cap: US$31.6m

An oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins.

Harvard Apparatus Regenerative Technology

Market Cap: US$31.6m

A clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.

Revium Rx

Market Cap: US$31.6m

A pre-clinical stage biopharmaceutical company, develops nano-liposomal particles (NLP) based pharmaceutical candidates.

Perseus Proteomics

Market Cap: JP¥4.7b

A drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan.

General Biologicals

Market Cap: NT$961.0m

Engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally.

TFBS Bioscience

Market Cap: NT$959.1m

A contract research organization, provides biological testing services in Taiwan.

Oncotelic Therapeutics

Market Cap: US$31.5m

A clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications.

Veritas In Silico

Market Cap: JP¥4.7b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

AlzeCure Pharma

Market Cap: SEK 293.0m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

CORESTEMCHEMON

Market Cap: ₩43.8b

A bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea.

NeuroSense Therapeutics

Market Cap: US$31.1m

A clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally.

Defence Therapeutics

Market Cap: CA$43.2m

Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.

iX Biopharma

Market Cap: S$40.0m

A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.

Solvonis Therapeutics

Market Cap: UK£23.1m

A clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders.

Cessatech

Market Cap: DKK 195.1m

A pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark.

NGeneBio

Market Cap: ₩43.0b

Develops in vitro diagnostics companion diagnostics products and bioinformatics software.

Gennex Laboratories

Market Cap: ₹2.7b

Manufactures and sells bulk drugs, intermediates, and biotech products.

Genesystem

Market Cap: ₩42.4b

A biotech engineering company, specializes in molecular testing solutions to target on-site testing needs.

Angion Biomedica

Market Cap: US$30.1m

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States.

Immuno-Biological Laboratories

Market Cap: JP¥4.5b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

Lunai Bioworks

Market Cap: US$30.0m

A pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands.

Genvor

Market Cap: US$29.9m

Develops plant-based defense technology designed to help farmers achieve global food security.

Andros PharmaceuticalsLtd

Market Cap: NT$902.9m

A biopharmaceutical company, engages in developing novel drug delivery platform technologies.

Biotechnology Assets

Market Cap: €25.3m

Develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally.

China Regenerative Medicine International

Market Cap: HK$228.2m

An investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China.

Genolution

Market Cap: ₩41.2b

Manufactures and sells IVD products in South Korea and internationally.

Oxygenta Pharmaceutical

Market Cap: ₹2.6b

Manufactures and sells pharmaceutical, medical, and veterinary preparations in India.

Yung Zip Chemical Ind

Market Cap: NT$889.8m

Yung Zip Chemical Ind. Co., Ltd., manufacturing, trading and sale of pharmaceuticals, pharmaceuticals, agricultural and industrial drugs, APIs, specialty chemicals and other related products internationally.

Ambalal Sarabhai Enterprises

Market Cap: ₹2.6b

Manufactures, markets, and supplies pharmaceutical products in India and internationally.

Ribomic

Market Cap: JP¥4.3b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

Han.biomedical

Market Cap: NT$879.5m

Develops structured biomaterials for tissue regeneration in Taiwan.

Genomtec

Market Cap: zł105.1m

Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.